Tadashi Namisaki Selected Research

Tadashi Namisaki Research Topics

Disease

57	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 10/2002
49	Fibrosis (Cirrhosis) 03/2024 - 10/2002
32	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2003
27	Neoplasms (Cancer) 04/2024 - 06/2003
17	Fatty Liver 12/2023 - 10/2006
12	Liver Diseases (Liver Disease) 12/2023 - 01/2009
12	Non-alcoholic Fatty Liver Disease 11/2023 - 10/2006
10	Alcoholic Fatty Liver 10/2022 - 07/2008
8	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2022 - 01/2017
8	Insulin Resistance 08/2020 - 01/2009
8	Carcinogenesis 03/2020 - 07/2003
7	Sarcopenia 12/2023 - 01/2020
6	Inflammation (Inflammations) 12/2023 - 01/2013
5	Hyperammonemia 08/2022 - 12/2017
5	Hepatic Encephalopathy 12/2021 - 12/2017
4	Cholangitis 04/2025 - 02/2018
4	Thrombophilia 02/2024 - 05/2019
4	Atrophy 12/2023 - 12/2021
4	Ascites 05/2023 - 08/2017
4	Liver Neoplasms (Liver Cancer) 01/2023 - 12/2014
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 12/2021 - 01/2013
4	Infections 06/2021 - 01/2017
3	Thrombosis (Thrombus) 02/2024 - 08/2017
3	Hypertension (High Blood Pressure) 10/2023 - 11/2017
3	Chronic Hepatitis B 10/2023 - 09/2017
3	Chronic Hepatitis (Chronic Active Hepatitis) 10/2023 - 11/2018
3	Type 2 Diabetes Mellitus (MODY) 10/2023 - 02/2016
3	Autoimmune Hepatitis 07/2023 - 06/2021
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 06/2023 - 07/2021
3	Acute-On-Chronic Liver Failure 01/2023 - 05/2020
3	Hemorrhage 01/2023 - 01/2017
3	Cholangiocarcinoma 01/2023 - 10/2018
3	Muscle Cramp (Cramp) 12/2020 - 01/2019
2	Choledocholithiasis 04/2025 - 10/2021
2	COVID-19 04/2025 - 11/2023

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2003
17	Amino Acids FDA Link 10/2023 - 07/2003
15	Choline (Choline Chloride)IBA 12/2023 - 07/2003
15	EndotoxinsIBA 12/2023 - 01/2013
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 12/2003
11	CDAA (Randox)IBA 10/2022 - 07/2003
10	LipopolysaccharidesIBA 04/2024 - 08/2017
10	von Willebrand FactorIBA 02/2024 - 02/2018
9	Losartan (Cozaar)FDA LinkGeneric 12/2023 - 05/2009
8	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2024 - 02/2016
8	Angiotensin IIIBA 12/2023 - 09/2003
8	CytokinesIBA 08/2022 - 05/2006
8	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2010 - 12/2003
7	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2024 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2002
7	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2023 - 09/2017
7	Angiotensin II Type 1 Receptor BlockersIBA 01/2022 - 05/2009
7	CollagenIBA 10/2020 - 12/2008
7	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2018 - 07/2003
6	EnzymesIBA 02/2024 - 07/2003
6	Messenger RNA (mRNA)IBA 04/2023 - 10/2002
6	Rifaximin (L 105)FDA Link 10/2022 - 12/2017
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2010 - 12/2003
5	lenvatinibIBA 04/2024 - 01/2021
5	Angiotensin Receptor AntagonistsIBA 12/2023 - 10/2014
5	ZincIBA 07/2023 - 06/2021
5	Toll-Like Receptor 4IBA 10/2022 - 06/2019
5	Branched-Chain Amino AcidsIBA 12/2021 - 01/2009
5	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 11/2017
4	AntigensIBA 01/2023 - 12/2020
4	AlbuminsIBA 10/2022 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 03/2015
4	Carrier Proteins (Binding Protein)IBA 10/2021 - 09/2017
4	Antiviral Agents (Antivirals)IBA 08/2020 - 01/2017
4	Sorafenib (BAY 43-9006)FDA Link 12/2019 - 10/2014
4	AldosteroneIBA 08/2017 - 05/2010
3	Interleukin-8 (Interleukin 8)IBA 04/2024 - 07/2005
3	Ethanol (Ethyl Alcohol)IBA 12/2023 - 01/2021
3	Hydroxyproline (4 Hydroxyproline)IBA 04/2023 - 02/2005
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2023 - 10/2016
3	Gemcitabine FDA Link 01/2023 - 08/2009
3	Tolvaptan FDA Link 05/2022 - 08/2017
3	Hyaluronic Acid (Hyaluronan)IBA 10/2021 - 08/2020
3	Tissue Inhibitor of MetalloproteinasesIBA 10/2021 - 08/2020
3	Matrix Metalloproteinases (MMPs)IBA 06/2021 - 10/2002
3	AntioxidantsIBA 06/2021 - 12/2020
3	DiureticsIBA 01/2021 - 08/2017
3	Therapeutic UsesIBA 12/2020 - 01/2008
3	Insulin (Novolin)FDA Link 04/2020 - 02/2016
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 02/2016
3	InterferonsIBA 09/2018 - 01/2008
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2016 - 05/2006
3	Chelating AgentsIBA 06/2011 - 09/2003
3	Perindopril FDA LinkGeneric 05/2006 - 12/2003
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2003 - 10/2002
2	AnticoagulantsIBA 04/2025 - 09/2020
2	ThrombospondinsIBA 02/2024 - 05/2019
2	Metalloproteases (Metalloproteinases)IBA 02/2024 - 05/2019
2	DisintegrinsIBA 02/2024 - 05/2019
2	Tight Junction ProteinsIBA 12/2023 - 08/2020

Therapy/Procedure

18	Therapeutics 05/2023 - 02/2005
8	Drug Therapy (Chemotherapy) 01/2023 - 12/2014
8	Oral Administration 10/2022 - 05/2005
4	Chemoprevention 10/2014 - 05/2005
3	Intraperitoneal Injections 01/2021 - 01/2019